Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Cell Biology|November 8, 2024
In vitro screening methods of novel immune checkpoint inhibitors related to T cell infiltration and anti-PD-1 resistanceZhuoying He, Xiuman Zhou, Youmei Xiao, et al.
Pharmaceutics|June 24, 2022
PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer CellHualian Zha, Zhanxue Xu, Xichao Xu, et al.
ACS Nano|June 10, 2020
Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in TransplantationZhanxue Xu, Hsiang-I Tsai, Youmei Xiao, et al.
Chembiochem : a European Journal of Chemical Biology|January 15, 2025
Self-assembled Palmitic Acid-modified Thymopentin Functions as a Delivery System of Nanovaccine for Cancer ImmunotherapyDanhong Chen, Xiaoyun Ye, Ran Xu, et al.
Journal of Medicinal Chemistry|March 20, 2026
A Bispecific Peptide-Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T CellsYuzhen Qian, Yixuan Sun, Yahong Wu, et al.
Nano Letters|February 24, 2025
Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer ImmunotherapyWanqiong Li, Xin Yang, Mengfan Wang, et al.
Cancer Immunology, Immunotherapy : CII|February 11, 2025
Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapyXiaoshuang Niu, Wenshan Zhao, Xiuman Zhou, et al.
Journal of the American Chemical Society|January 22, 2026
An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer ImmunotherapyYoumei Xiao, Xiuman Zhou, Xiaoshuang Niu, et al.
Biomaterials Research|June 30, 2023
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinomaYoumei Xiao, Zhanxue Xu, Yuan Cheng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 29, 2023
Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapyXin Yang, Wanqiong Li, Shuzhen Li, et al.
Pageof 2